# This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.

> **NCT01705197** · PHASE3 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 195 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Avanafil 100 or 200mg

## Key facts

- **NCT ID:** NCT01705197
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-11
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2017-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01705197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01705197, "This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01705197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*